Understanding how iron-based enzymes can improve drug synthesis
The role of geometric structure in avoidance of oxygen rebound to enable aliphatic halogenation and oxacyclization by non-heme Fe(IV)-oxo (ferryl) complexes
This study is looking at how certain enzymes that need iron can help make important medicines better and more eco-friendly, which could lead to new or improved treatments for patients like you.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Pennsylvania State University, the NIH-funded |
| Lab location | 1 site (University Park, United States) |
| Project ID | NIH-10876270 on NIH RePORTER |
What this research studies
This research investigates how specific iron-dependent enzymes can be utilized to enhance the synthesis of important drugs. By examining the geometric structure of these enzymes, the project aims to understand how they catalyze various chemical reactions, including hydroxylation and halogenation. The researchers will use advanced spectroscopic techniques to analyze the behavior of these enzymes and their interactions with substrates, which could lead to more efficient and environmentally friendly drug production methods. Patients may benefit indirectly through the development of new or improved medications resulting from this research.
Who could benefit from this research
Good fit: Patients who may benefit from this research are those who require medications that could be synthesized using the improved methods developed through this project.
Not a fit: Patients who are not seeking new treatments or who do not require medications synthesized through these specific enzymatic processes may not benefit.
Why it matters
Potential benefit: If successful, this research could lead to more efficient and sustainable methods for producing vital medications.
How similar studies have performed: Other research has shown promise in using similar enzymatic approaches for drug synthesis, indicating a potential for success in this area.
Where this research is happening
University Park, United States
- Pennsylvania State University, the — University Park, United States (Active)
Researchers
- Principal investigator: Silakov, Alexey — Pennsylvania State University, the
- Study coordinator: Silakov, Alexey
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.